Author Correction: Clinical, pathological, and PAM50 gene expression features of HER2-low breast cancer

Affiliations

• ¹ Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Italy.
• ² Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain.
• ³ SOLTI Breast Cancer Research Group, Barcelona, Spain.
• ⁴ Department of Medical Oncology, Hospital Clínic, Barcelona, Spain.
• ⁵ Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
• ⁶ Department of Medical Oncology, Ospedale Policlinico San Martino, University of Genova, Genova, Italy.
• ⁷ Department of Pathology, Hospital Clínic, Barcelona, Spain.
• ⁸ INCLIVA Biomedical Research Institute, Hospital Clínico Universitario Valencia, University of Valencia, Valencia, Spain.
• ⁹ Pathology Department, Campus Bio-Medico University, Rome, Italy.
• ¹⁰ Vall d´Hebron University Hospital, Barcelona, Spain.
• ¹¹ GEICAM, Grupo Español de Investigación en Cáncer de Mama, Madrid, Spain.
• ¹² Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain.
• ¹³ Instituto Valenciano de Oncología (IVO), Valencia, Spain.
• ¹⁴ Centro de Pesquisa Clínica Hospital São Lucas da PUCRS, Porto Alegre, Brazil.
• ¹⁵ LACOG, Latin American Cooperative Oncology Group, Porto Alegre, Brazil.
• ¹⁶ Hospital Universitario Clínico Valencia, Valencia, Spain.
• ¹⁷ Biomedical Research Centre Network in Cancer (CIBERONC), Valencia, Spain.
• ¹⁸ Hospital Gregorio Marañon, Madrid, Spain.
• ¹⁹ Department of Neuroscience, Reproductive Sciences and Dentistry, University of Naples Federico II, Naples, Italy.
• ²⁰ Translational Genomics and Targeted Therapeutics in Solid Tumors, August Pi i Sunyer Biomedical Research Institute, Barcelona, Spain. alprat@clinic.cat.
• ²¹ SOLTI Breast Cancer Research Group, Barcelona, Spain. alprat@clinic.cat.
• ²² Department of Medical Oncology, Hospital Clínic, Barcelona, Spain. alprat@clinic.cat.